Eye - Photo by Amanda Dalbjörn on Unsplash

Industry

-

Aerie Pharmaceuticals Announces First Participant Dosed in the COMET-3 Study of its TRPM8 agonist AR-15512 for the Treatment of Dry Eye Disease

Source: Aerie Pharmaceuticals

Eye - Photo by Umesh Soni on Unsplash

Industry

-

Aerie Pharmaceuticals Announces First Participant Dosed in the Phase 3 Registrational COMET-2 Study of AR-15512 for the Treatment of Dry Eye Disease

Source: Aerie Pharmaceuticals

eye

Industry

-

Aerie Pharmaceuticals completes enrollment of its Phase 2b clinical trial of AR-15512 (TRPM8 agonist) ophthalmic solution for the treatment of patients with dry eye disease

Source: Aerie Pharmaceuticals

Ion Channel library
About
Credits

artem@ionchannellibrary.com

© 2023 Artem Kondratskyi

Terms of Use

Privacy policy